Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Follow us on Twitter

  • The Food and Drug Administration has authorized a clinical trial of stem cells extracted and cultured from patients… https://t.co/68QuQj2ik5
    about 9 hours ago
  • New post on Science and Enterprise: FDA Clears Stem Cell Trial for Multiple Sclerosis https://t.co/iLohWcDKEC #Science #Business
    about 9 hours ago
  • A venture philanthropy group is funding an initiative to find digital data indicators of early onset of Alzheimer's… https://t.co/YBoAZKBjBw
    about 1 day ago
  • New post on Science and Enterprise: Alzheimer’s Digital Biomarkers Project Gains New Funds https://t.co/lxhfwd4Bzi #Science #Business
    about 1 day ago
  • Shionogi starts clinical test on oral COVID drug | NHK WORLD-JAPAN News https://t.co/EAQvk9nGjw
    about 2 days ago

Please share Science & Enterprise

Biomanufacturing Materials Company Issues $500M IPO

Wall Street sign

Zymergen Inc., a developer of materials made with synthetic biology for industrial products is raising $500 million in its initial public stock offering. . . . → Read More: Biomanufacturing Materials Company Issues $500M IPO

Concrete Mfring Processes Win CO2 Conversion Challenge

Gaurav Sant

Two companies with alternative techniques for manufacturing concrete won a challenge competition to convert carbon dioxide into useful products. . . . → Read More: Concrete Mfring Processes Win CO2 Conversion Challenge

Synthetic DNA Company Raises $24M in Early Funds

DNA illustration

A company with a technology it says is simpler and more like natural processes to produce synthetic DNA is raising $24 million in its first venture round. . . . → Read More: Synthetic DNA Company Raises $24M in Early Funds

Infographic – Covax Begins Vaccine Deliveries

Chart: Covax deliveries

Deliveries so far represent a small fraction of the allotments to those countries, with deliveries for other allotments not yet underway. . . . → Read More: Infographic – Covax Begins Vaccine Deliveries

Cell-Based Fish Company Gains $8.25M in Seed Funds

Bluu Bioscience founders

The start-up enterprise Bluu Biosciences is underway creating seafood products from fish stem cells, and raising $US 8.25 million in seed funds. . . . → Read More: Cell-Based Fish Company Gains $8.25M in Seed Funds

Test Vaccine Protects Against Wide Coronavirus Range

Two piglets

Researchers at two Virginia universities developed an experimental vaccine that in tests with pigs protects against SARS-CoV-2 and other coronaviruses. . . . → Read More: Test Vaccine Protects Against Wide Coronavirus Range

Biotech Manufacturer Gains $525M in New Funds

BaseCamp lab

A company providing specialized lab and manufacturing services for cell and gene therapy developers is raising $525 million in its third venture funding round. . . . → Read More: Biotech Manufacturer Gains $525M in New Funds

CEPI Funding SARS-CoV-2 Variant Vaccines

SARS-Cov-2 virus

CEPI, an international consortium, is funding development of vaccines to protect against SARS-CoV-2 mutations, starting with B.1.351 discovered in Brazil. . . . → Read More: CEPI Funding SARS-CoV-2 Variant Vaccines

Microbe Therapy Maker Expands, Adds Venture Funds

C. difficile in petri dish

A company providing manufacturing services for microbiome drug developers is expanding its facilities, with an infusion of new venture funds. . . . → Read More: Microbe Therapy Maker Expands, Adds Venture Funds

$100M Challenge Seeks Carbon Removal Technologies

Climate change skyline

An XPrize challenge competition, sponsored by Elon Musk, is seeking new technologies that remove large quantities of carbon dioxide from the atmosphere. . . . → Read More: $100M Challenge Seeks Carbon Removal Technologies